Zentalis Pharmaceuticals, Inc.

ZNTL

$3.58

Name : Zentalis Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $254,847,136.00

EPSttm : -1.74

Zentalis Pharmaceuticals, Inc.

$3.58

0.00%

$0.00000000000000

ZNTL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.71

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.01

EPS Last/This Y

0.17

EPS This/Next Y

0.18

Price

3.59

Target Price

6.5

Analyst Recom

2.11

Performance Q

16.99

Upside

-1,169.3%

Beta

1.98

Ticker: ZNTL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ZNTL	4.12	0.07	0.72	8075
2026-05-12	ZNTL	4.28	0.07	0.50	8102
2026-05-13	ZNTL	4.29	0.07	0.00	8102
2026-05-14	ZNTL	4.1	0.07	3.00	8069
2026-05-15	ZNTL	4.06	0.06	0.51	8017
2026-05-18	ZNTL	3.64	0.06	0.02	6183
2026-05-19	ZNTL	3.54	0.06	0.00	6785
2026-05-20	ZNTL	3.7	0.05	0.00	6818
2026-05-21	ZNTL	4.14	0.05	0.00	7022
2026-05-22	ZNTL	4.06	0.05	0.00	7056
2026-05-26	ZNTL	3.97	0.05	0.01	7060
2026-05-27	ZNTL	4.03	0.05	0.00	7100
2026-05-28	ZNTL	4.05	0.05	0.01	7104
2026-05-29	ZNTL	4.01	0.05	0.00	7244
2026-06-02	ZNTL	3.95	0.05	0.00	7402
2026-06-03	ZNTL	3.73	0.05	0.00	7481
2026-06-04	ZNTL	3.88	0.05	0.00	7503
2026-06-05	ZNTL	3.65	0.05	0.00	7498
2026-06-08	ZNTL	3.58	0.05	0.11	7507
2026-06-09	ZNTL	3.58	0.05	0.00	7533
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ZNTL	4.12	21.9	-	-1.77
2026-05-12	ZNTL	4.28	21.9	-	-1.77
2026-05-13	ZNTL	4.29	21.9	-	-1.77
2026-05-14	ZNTL	4.10	21.9	-	-1.77
2026-05-15	ZNTL	4.06	21.9	-	-1.77
2026-05-18	ZNTL	3.65	21.9	-	-1.77
2026-05-19	ZNTL	3.54	21.9	-	-1.77
2026-05-20	ZNTL	3.69	21.9	-	-1.83
2026-05-21	ZNTL	4.14	21.9	-	-1.83
2026-05-22	ZNTL	4.06	-24.7	-	-1.74
2026-05-26	ZNTL	3.96	-24.7	-	-1.74
2026-05-27	ZNTL	4.03	-24.7	-	-1.74
2026-05-28	ZNTL	4.05	-24.7	-	-1.74
2026-05-29	ZNTL	4.00	-24.7	-	-1.74
2026-06-01	ZNTL	3.99	-24.7	-	-1.74
2026-06-02	ZNTL	3.93	-24.7	-	-1.74
2026-06-03	ZNTL	3.72	-24.7	-	-1.74
2026-06-04	ZNTL	3.88	-24.7	-	-1.74
2026-06-05	ZNTL	3.65	-24.7	-	-1.74
2026-06-08	ZNTL	3.57	-24.7	-	-1.74
2026-06-09	ZNTL	3.59	-24.7	-	-1.74
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ZNTL	-4.61	-17.29	11.38
2026-05-12	ZNTL	-4.17	-17.29	12.00
2026-05-13	ZNTL	-4.17	-17.29	12.00
2026-05-14	ZNTL	-4.17	-17.29	12.00
2026-05-15	ZNTL	-4.15	-17.29	11.93
2026-05-18	ZNTL	-4.17	-18.31	11.93
2026-05-19	ZNTL	-4.17	-18.31	11.93
2026-05-20	ZNTL	-4.17	-18.31	11.93
2026-05-21	ZNTL	-4.17	-18.31	11.93
2026-05-22	ZNTL	-4.17	-18.31	11.93
2026-05-26	ZNTL	-4.17	-1.02	11.93
2026-05-27	ZNTL	-4.17	-1.02	11.93
2026-05-28	ZNTL	-4.17	-1.02	10.71
2026-05-29	ZNTL	-4.17	-1.02	10.71
2026-06-02	ZNTL	-4.17	-1.44	10.71
2026-06-03	ZNTL	-4.17	-1.44	10.71
2026-06-04	ZNTL	-4.17	-1.44	10.71
2026-06-05	ZNTL	-4.17	-1.44	10.71
2026-06-08	ZNTL	-4.17	-1.44	10.71
2026-06-09	ZNTL	-4.17	-1.44	10.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.5

Avg. EPS Est. Current Quarter

-0.46

Avg. EPS Est. Next Quarter

-0.49

Insider Transactions

-4.17

Institutional Transactions

-1.44

Beta

1.98

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.9

Max Drawdown 5-Year %

-98.8

Target Price

6.5

P/E

Forward P/E

PEG

P/S

P/B

1.39

P/Free Cash Flow

EPS

-1.74

Average EPS Est. Cur. Y

-1.74

EPS Next Y. (Est.)

-1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.22

Return on Equity vs Sector %

-95.4

Return on Equity vs Industry %

-79.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ ZNTL Healthcare

$3.58

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

4/20

Pullback

21/25

Volume

11/15

Valuation

12/20

TP/AR

3/10

Options

7/10

RSI

41.8

Range 1M

23%

Sup Dist

2.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

9/30

Estimates

2/20

Inst/Vol

3/15

Options

8/10

EPS Yr

-1.5%

EPS NY

13.5%

52W%

43.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +81.6% upside

Quality

3/30

Valuation

16/30

Growth

8/25

Stability

6/10

LT Trend

0/5

Upside

+81.6%

Quality

Zentalis Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 106

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.

ZNTL

Latest News

—

Caricamento notizie per ZNTL…

stock quote shares ZNTL – Zentalis Pharmaceuticals, Inc. Stock Price stock today

news today ZNTL – Zentalis Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ZNTL – Zentalis Pharmaceuticals, Inc. yahoo finance google finance

stock history ZNTL – Zentalis Pharmaceuticals, Inc. invest stock market

stock prices ZNTL premarket after hours

ticker ZNTL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ZNTL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y